Standards for adult immunization practices

被引:79
作者
Poland, GA
Shefer, AM
McCauley, M
Webster, PS
Whitley-Williams, PN
Peter, G
机构
[1] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN USA
[2] Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[5] Brown Univ, Sch Med, Providence, RI 02912 USA
关键词
D O I
10.1016/S0749-3797(03)00120-X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Since the Standards for Adult Immunization Practices were first published in 1990, healthcare researchers and providers have learned important lessons on how to better achieve and maintain high vaccination rates in adults. The success rate of childhood immunization far exceeds the success rate of adult immunization. Thus, information and practices that will produce higher success rates for adult vaccination are crucial, resulting in overall societal cost savings and substantial reductions in hospitalizations and deaths. The Standards, which were developed to encourage the best immunization practices, represent the collective efforts of more than 100 people from more than 60 organizations. The revised Standards are more comprehensive than the 1990 Standards and focus on the accessibility and availability of vaccines, proper assessment of patient vaccination status, opportunities for patient education, correct procedures for administering vaccines, implementation of strategies to improve vaccination rates, and partnerships with the community to reach target patient populations. The revised Standards are recommended for use by all healthcare professionals and all public and private sector organizations that provide immunizations for adults. All who are involved in adult immunization should strive to follow the Standards in order to create the same level of success achieved by childhood vaccination programs and to meet the Healthy People 2010 goals.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 24 条
[1]  
[Anonymous], 2001, Morbidity and Mortality Weekly Report, V50, P532
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]  
[Anonymous], 1999, MMWR, V48, DOI [DOI 10.1037/E547822006-001, 10.1037/e547822006-001]
[4]  
[Anonymous], 2000, HLTH PEOPL 2010, V2nd
[5]   Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults [J].
Briss, PA ;
Rodewald, LE ;
Hinman, AR ;
Shefer, AM ;
Strikas, RA ;
Bernier, RR ;
Carande-Kulis, VG ;
Yusuf, HR ;
Ndiaye, SM ;
Williams, SM .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2000, 18 (01) :97-140
[6]   PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY - AN EVALUATION OF CURRENT RECOMMENDATIONS [J].
BUTLER, JC ;
BREIMAN, RF ;
CAMPBELL, JF ;
LIPMAN, HB ;
BROOME, CV ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (15) :1826-1831
[7]  
CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1
[8]  
*CDCP, 2001, VACC FACT SHEET
[9]  
*CDCP, 2001, VIR HEP B FACT SHEET
[10]  
Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P399